Evidence map›Paper›PMID 25879811›Full record

ArticleBMC infectious diseases2015

The significance of Lactobacillus crispatus and L. vaginalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African women.

Vicky Jespers, Janneke van de Wijgert, Piet Cools, Rita Verhelst, Hans Verstraelen, Sinead Delany-Moretlwe, Mary Mwaura, Gilles F Ndayisaba, Kishor Mandaliya, Joris Menten and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 2 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 2 syntheses or guidelines pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. ProbioticFrontiers in cellular and infection microbiology · 2021
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Improvement of abnormal vaginal flora in Ugandan women by self-testing and short use of intravaginal antimicrobials.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017
    Trial
  9. Trial
  10. Article
  11. Review
  12. Group BMedical principles and practice : international journal of the Kuwait University, Health Science Centre · 2026
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Second trimester vaginalFrontiers in global women's health · 2024
    Article
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 6 countries.

Vicky JespersDepartment of Public Health, Unit of Epidemiology and Control of HIV/STD, Institute of Tropical Medicine, Nationalestraat 155, B-2000, Antwerp, Belgium. vjespers@itg.be.
Janneke van de WijgertDepartment of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK. j.vandewijgert@liverpool.ac.uk.
Piet CoolsLaboratory Bacteriology Research, University Gent, Ghent, Belgium. piet.cools@ugent.be.
Rita VerhelstInternational Center for Reproductive Health (ICRH), Ghent University, Ghent, Belgium. riet7@icloud.com.
Hans VerstraelenDepartment of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium. hans.verstraelen@ugent.be.
Sinead Delany-MoretlweWits Reproductive Health & HIV Institute, University of Witwatersrand, Johannesburg, South Africa. sdelany@wrhi.ac.za.
Mary MwauraICRH Kenya, Mombasa, Kenya. mwaura.maryw@gmail.com.
Gilles F NdayisabaRinda Ubuzima, Kigali, Rwanda. ndayisaba@gmail.com.
Kishor MandaliyaICRH Kenya, Mombasa, Kenya. kishor@icrhk.org.
Joris MentenDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. jmenten@itg.be.
Liselotte HardyDepartment of Public Health, Unit of Epidemiology and Control of HIV/STD, Institute of Tropical Medicine, Nationalestraat 155, B-2000, Antwerp, Belgium. lhardy@itg.be.
Tania CrucittiDepartment of Clinical Sciences, HIV/STI Reference Laboratory, Institute of Tropical Medicine, Antwerp, Belgium. tcrucitti@itg.be.
Vaginal Biomarkers Study Group
Instituut voor Tropische Geneeskunde · BEGhent University · BEUniversity of Liverpool · GBUniversity of Rwanda · RWUniversity of the Witwatersrand · ZAInternational Centre for Reproductive Health Kenya · KE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWomen in sub-Saharan Africa are vulnerable to acquiring HIV infection and reproductive tract infections. Bacterial vaginosis (BV), a disruption of the vaginal microbiota, has been shown to be strongly associated with HIV infection. Risk factors related to potentially protective or harmful microbiota species are not known.

methodsWe present cross-sectional quantitative polymerase chain reaction data of the Lactobacillus genus, five Lactobacillus species, and three BV-related bacteria (Gardnerella vaginalis, Atopobium vaginae, and Prevotella bivia) together with Escherichia coli and Candida albicans in 426 African women across different groups at risk for HIV. We selected a reference group of adult HIV-negative women at average risk for HIV acquisition and compared species variations in subgroups of adolescents, HIV-negative pregnant women, women engaging in traditional vaginal practices, sex workers and a group of HIV-positive women on combination antiretroviral therapy. We explored the associations between presence and quantity of the bacteria with BV by Nugent score, in relation to several factors of known or theoretical importance.

resultsThe presence of species across Kenyan, South African and Rwandan women was remarkably similar and few differences were seen between the two groups of reference women in Kenya and South Africa. The Rwandan sex workers and HIV-positive women had the highest G. vaginalis presence (p = 0.006). Pregnant women had a higher Lactobacillus genus mean log (7.01 genome equivalents (geq)/ml) compared to the reference women (6.08 geq/ml). L. vaginalis (43%) was second to L. iners (81.9%) highly present in women with a normal Nugent score. Recent sexual exposure negatively affected the presence of L. crispatus (<0.001), L. vaginalis (p = 0.001), and Lactobacillus genus (p < 0.001). Having more than one sexual partner in the last three months was associated with an increased prevalence of G. vaginalis (p = 0.044) and L. iners (p = 0.001).

conclusionsAlthough the composition of species across the studied African countries was similar, the presence of protective species i.e. L. crispatus and L. vaginalis in women with a normal Nugent score appeared lower compared to non-African studies. Furthermore, Lactobacillus species were negatively affected by sexual behavioural. Strategies to support protective Lactobacillus species are urgently needed.

trial registrationThe study is registered at the Trial Registration at the National Health Research Ethics Council South Africa with the number DOH2709103223.

Indexed as

CoitusActinobacteriaAdolescentAdultCandida albicansCarrier StateCase-Control StudiesCross-Sectional StudiesEscherichia coliFemaleGardnerella vaginalisHIV InfectionsHumansKenyaLactobacillusPolymerase Chain Reaction

Identifiers

PMID25879811
PMCPMC4351943
OpenAlexW2016932246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.